Hasiera IPHASE DS8201a

IPHASE DS8201a

Deskribapen laburra:

DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

KONTAKTU ORAIN Gehitu erosketa saskira

Produktuaren xehetasuna

Produktuen etiketak

Produktuen deskribapena DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

Kategoria:
Cathepsin
Elementu ZENB.:
015200.01
Unitatearen tamaina:
50uL,2mg/mL
Ehuna:
N/A
Espezie:
N/A
Biltegiratze baldintzak eta garraioa:
Gorde -70°C-tan. Izotz lehorra entregatu.